Millennium Group (NHP) reports shared control of 1.91M Class A shares
Rhea-AI Filing Summary
National Healthcare Properties, Inc. Schedule 13G reports that Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander each disclose shared voting and dispositive power over 1,912,863 shares of Class A Common Stock, representing 4.3% of the class. The cover notes the reporting persons briefly exceeded a 5% threshold on 04/22/2026 and ceased to be beneficial owners above 5% by the filing date.
The filing lists issuer headquarters at 540 Madison Avenue, New York, and includes a Joint Filing Agreement dated April 28, 2026. Signatures are provided by Gil Raviv and Israel A. Englander.
Positive
- None.
Negative
- None.
Key Figures
Shared voting/dispositive power: 1,912,863 shares
Percent of class: 4.3%
CUSIP: 42226B501
+3 more
6 metrics
Shared voting/dispositive power
1,912,863 shares
reported on cover pages (Class A Common Stock)
Percent of class
4.3%
percent of Class A Common Stock reported on cover pages
CUSIP
42226B501
Class A Common Stock CUSIP listed on cover
Date of >5% ownership
04/22/2026
date reporting persons acquired beneficial ownership above 5%
Joint Filing Agreement date
April 28, 2026
Exhibit I: Joint Filing Agreement among reporting persons
Issuer address
540 Madison Avenue, New York, NY
issuer principal executive offices listed in Item 1(b)
Key Terms
Schedule 13G, beneficially owned, Joint Filing Agreement, shared dispositive power
4 terms
Schedule 13G regulatory
"Item 1. Name of issuer: National Healthcare Properties, Inc."
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
beneficially owned financial
"Item 4. (a) Amount beneficially owned: See response to Item 9"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Joint Filing Agreement legal
"Exhibit I: Joint Filing Agreement, dated as of April 28, 2026"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does NHP Schedule 13G say about Millennium's holdings?
The filing states Millennium-affiliated entities report shared voting and dispositive power over 1,912,863 shares, equal to 4.3% of Class A Common Stock. The holders executed a Joint Filing Agreement on April 28, 2026 and list their New York address.
Did Millennium exceed the 5% ownership threshold in NHP?
Yes; the filing discloses Millennium acquired beneficial ownership above 5% on 04/22/2026. It also states they ceased to be beneficial owners above 5% by the date of this filing, with current reported ownership at 4.3% of the class.
Who is the reporting person for the NHP Schedule 13G?
The reporting parties are Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander. Addresses are listed at 399 Park Avenue, New York, and filings include a Joint Filing Agreement dated April 28, 2026.
What voting and dispositive powers are reported on NHP Schedule 13G?
Each reporting person discloses 0 sole voting and dispositive power and 1,912,863 shared voting and dispositive power over Class A shares, as shown on the cover pages and Item 6–8 responses.
What is the issuer and CUSIP listed on the filing for NHP?
The issuer is National Healthcare Properties, Inc., Class A Common Stock, par value $0.01 per share, with CUSIP 42226B501. The issuer's principal executive office is listed at 540 Madison Avenue, New York.